Yun Xinyao will continue to communicate with you, hoping that through the smooth development of the research, more effective treatment methods will be brought to the patients with advanced NSCLC who have received EGFR TKI treatment and drug resistance in the future, and we also hope that we can establish a long-term cooperative relationship with you through this research cooperation. Thank you!
正在翻译中..